About Vitalis
Built on Verification, Not Just Claims
Vitalis Research Compounds was founded on a single principle: researchers deserve to know exactly what is in every vial they order. Every compound we supply is independently tested before it ships — no exceptions.
Our Mission
Reliable Supply for Serious Research
The research peptide market has a quality problem. Inconsistent purity, missing documentation, and unverified sourcing make it difficult for scientists to trust their reagents — and unreliable reagents produce unreliable data.
Vitalis was built to solve that. We source from GMP-aligned synthesis partners, require independent third-party testing on every batch, and make the full certificate of analysis available upon request. Batch IDs are traceable from synthesis to delivery.
We supply exclusively to qualified researchers for in vitro laboratory use. Our catalog is intentionally focused — six rigorously characterized compounds rather than a broad, poorly documented range.
Quality Standards
What We Test on Every Batch
HPLC Purity Verification
Every batch is analyzed by high-performance liquid chromatography (HPLC-UV) before release. We only ship compounds that meet our internal purity standards — certificates of analysis are available upon request.
Mass Spectrometry Confirmation
Electrospray ionization mass spectrometry (ESI-MS) confirms molecular identity on every batch. No compound ships without a confirmed [M+H]⁺ match to the target sequence.
Endotoxin Testing (LAL)
Limulus amebocyte lysate (LAL) chromogenic assay is performed on every batch. We require <1.0 EU/mg — the standard threshold for research-grade peptides.
Sterility & Appearance
Sterility testing confirms no microbial growth. Visual inspection and moisture content (Karl Fischer titration) are documented in the batch testing record.
Sourcing Process
From Synthesis to Your Lab
Synthesis Partner Selection
We work exclusively with GMP-aligned peptide synthesis facilities that use Fmoc solid-phase peptide synthesis (SPPS) with validated coupling reagents and resin systems.
Pre-Release QC at Synthesis Site
Before shipment to our facility, each batch undergoes preliminary HPLC and MS screening at the synthesis site. Batches that fail preliminary QC are rejected outright.
Independent Third-Party Testing
Accepted batches are sent directly to our independent testing partners — Intertek, Eurofins, or SGS — for full analytical testing. We do not release any batch until the third-party report is received.
Batch Assignment & Documentation
Each passing batch receives a unique Vitalis batch ID (e.g. VRC-BPC-2406) and internal testing documentation. Batch records are retained and can be referenced by ID.
Lyophilization & Packaging
Compounds are lyophilized under controlled conditions and sealed in sterile vials under inert atmosphere. Cold-chain packaging is used for all shipments.
Testing Partners
Independent, Accredited Laboratories
We rotate testing across three ISO/IEC 17025 accredited contract research organizations. Batch assignments are noted on each certificate of analysis.
Intertek Pharmaceutical Services
HPLC, ESI-MS, LAL Endotoxin
ISO/IEC 17025 AccreditedEurofins Scientific
Peptide Purity, Sterility, Moisture
ISO/IEC 17025 AccreditedSGS Life Sciences
Full Panel Testing, Identity Confirmation
ISO/IEC 17025 Accredited100%
Batches Third-Party Tested
CoA
Available Upon Request
HPLC
Verified Every Batch
See the Catalog
Browse our full compound catalog with batch details and independent lab verification. CoA available upon request.
For Research Purposes Only. All compounds supplied by Vitalis Research Compounds are intended solely for in vitro laboratory research by qualified scientists. Not for human consumption, diagnostic, therapeutic, or veterinary use. See our Research Use Disclaimer.